Search
Sumario de resultados
TIpos de contenido
Fecha
-
NewBCN HEALTH publishes a study evaluating the incidence, mortality and medical costs associa...
BCN HEALTH conducted a retrospective study based on the records of patients diagnosed with a melanoma and treated in Spanish public and private hospitals between January of 2011 and December of 2017.
-
NewGallery | This is how #BIOSPAIN2023 went
BIOSPAIN 2023 brought together the global biotechnology industry in Barcelona and concluded its eleventh edition with record-breaking participation numbers. Over 2,100 attendees and more than 220
-
New"BIOSPAIN allows the creation of a sense of belonging to a leading sector that is already ...
BIOSPAIN, the largest biotechnology event organised by a national bioindustry association in Europe, closed its XI edition in Barcelona on 28 September after three days of events with AseBio as
-
NewORYZON receives two grants to further explore the role of epigenetic targets in the treatm...
Two collaborative projects with public research centers with a global budget of 2.3 million euros.
-
NewORYZON to provide corporate progress updates at several events in October
Oryzon Genomics, S.A., a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that its management will give
-
NewHOFFMANN EITLE Madrid & Barcelona celebrate their 10th anniversary in BIOSPAIN
As part of BIOSPAIN, from 26 to 28 September in Barcelona, HOFFMANN EITLE Madrid & Barcelona celebrated its tenth anniversary with a cocktail party that brought together clients, representatives of
-
NewBIOSPAIN 2023 concludes its eleventh edition with record-breaking attendance
Over 2,100 attendees and more than 220 exhibitors gathered over the course of the three-day congress.
-
Press releaseBIOSPAIN 2023 concludes its eleventh edition with record-breaking participation figures
The President of the Generalitat de Catalunya, Pere Aragonès i Garcia, and the General Manager of Amgen and member of the Board of Directors of AseBio and the Board of Trustees of Biocat, Fina Lladós
-
NewGenome editing techniques can help address the challenges facing agriculture and the plane...
Biotechnology enables the transformation of certain types of waste into raw materials for industry, avoiding their disposal in landfills and reducing the footprint of processes and products.
-
Press release
Genome editing techniques can help address the challenges facing agriculture and the plane...
Ensuring food security and mitigating the impacts of climate change will not be possible without innovation in agriculture. Through food waste and the insect industry, proteins are being produced in a
-
NewExternal funding in the biotechnology sector will help achieve strategic autonomy for Spai...
Strategic autonomy in the European healthcare sector can be supported in three areas: simplifying the European regulatory framework, reducing administrative burdens, and removing barriers to
-
Press release
External funding in the biotechnology sector will help achieve strategic autonomy for Spai...
The majority of biotechnology companies are small and micro-enterprises that do not have products on the market and do not generate the necessary resources to finance their activities. There is an
-
NewThe biotechnology industry has become a key player in the fight against antimicrobial resi...
The sector has radically transformed the discovery of new drugs and therapeutic solutions. Worldwide, there are over 300 approved medications for approximately 250 indications and a thousand molecules
-
Press release
The biotechnology industry has become a key player in the fight against antimicrobial resi...
The sector has radically transformed the discovery of new drugs and therapeutic solutions. Worldwide, there are over 300 approved medications for approximately 250 indications and a thousand molecules
-
New#BIOSPAIN2023Interview | "In Spain, access to suitable financing can be a challenge, espec...
We spoke with Damià Tormo, General Partner & Co-founder of Columbus Venture Partners and Bronze Sponsor of BIOSPAIN 2023, about the challenges in the biotechnology sector.
-
New#BIOSPAIN2023 Interview | "Open Innovation Test Beds (OITBs) are inherently multinational ...
Ángel del Pozo, Deputy Manager of Programs Strategy at Biokeralty Research Institute and Scientific and Technical Manager of Safe-N-Medtech, discusses the current landscape of OITBs as a Bronze
-
NewBIOSPAIN 2023 brings together the global biotechnology industry in Barcelona
The inauguration ceremony featured the President of AseBio, Ana Polanco; the Secretary of State for Trade, Xiana Margarida Méndez; the Minister of Business and Labor of the Government of Catalonia
-
New#BIOSPAIN2023Interview | "Exploring space with robots and humans opens new frontiers and a...
We interview Sara García Alonso, Molecular Biologist & member of the Astronaut Reserve of the European Space Agency (ESA). She shares her experience as one of the keynote speakers at BIOSPAIN 2023.
-
New#BIOSPAIN2023 Interview | "The biotechnology sector in Spain presents a very dynamic lands...
José María Giménez Arnau, Chief Scientific & Medical Officer of ESTEVE, Gold Sponsor of BIOSPAIN 2023, discusses the state of the 'biotech' sector and shares the keys to the company's new innovation
-
New#BIOSPAIN2023Interview | "The biotechnology sector is in full expansion"
More than 100 investors will gather at BIOSPAIN 2023, an international benchmark event in the biotechnology sector. Among them is Wellington Partners. We talked to Arturo Urrios, Venture Advisor.
-
New#BIOSPAIN2023Interview | This is how Acelera Startups Sectorial Biotech works, the proposa...
Antonio López, CEO of SILO, a Bronze Sponsor of BIOSPAIN 2023, shares all the details about the Acelera Startups Sectorial Biotech program.